INSIDER
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

Robinhood Chain…
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodology
Alerts on Telegram

Congress trades and big insider sales, sent the day they're filed. Free.

Open in Telegram
OverviewFollow the MoneyDaily BriefLiveCongressDirectoryCorporate InsidersPlanned Sales & StakesGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyTelegram alerts
03 · Corporate insiders

Form 4 filings

Officers, directors and 10% owners must report trades within two business days on SEC Form 4. INSIDER parses each filing's XML from EDGAR. By default only discretionary open-market purchases and sales are shown; grants, option exercises and tax withholding are one click away.

Form 4 transactions

Cluster activity · 60d

Most active filers

Companies with the most Form 4 filings
Data sources
SEC Form 41h ago
House PTR1h ago
SEC 13F1h ago
Robinhood Chain1h ago

Most active filers · 30d

  1. 01Kurtz George0B / 215S215 trades$52.62M
  2. 02FWFogarty Patrick W0B / 150S150 trades$600K
  3. 03SPSaba Capital Management, L.P.65B / 19S · 11 late84 trades$21.64M
  4. 04ATAdair Kathleen Theresa52B / 0S · 52 late52 trades$18K
  5. 05AJAllaire Jeremy0B / 50S50 trades$4.26M
  6. 06Wilhelmsen Arne Alexander0B / 47S47 trades$241.96M
  7. 07SJSheena Jonathan0B / 45S45 trades$3.01M
  8. 08SISarowitz Steven I2B / 34S36 trades$22.46M
  9. 09SLSpeiser Michael L0B / 35S35 trades$14.00M
  10. 10RARothblatt Martine A0B / 33S33 trades$5.50M

Cluster activity · 60d

  1. BUYTSMTAIWAN SEMICONDUCTOR MANUFACTURING CO LTDNov 5 – Nov 1732 insiders$917K
  2. SELLDRDDRDGOLD LTDOct 27 – Oct 2710 insiders$1.23M
  3. BUYMTDRMatador Resources CoNov 5 – Nov 179 insiders$893K
  4. SELLMSIMotorola Solutions, Inc.Nov 6 – Nov 168 insiders$42.58M
  5. SELLFFIVF5, INC.Nov 3 – Nov 58 insiders$8.37M
  6. SELLIBEXIBEX LtdNov 9 – Nov 167 insiders$3.36M
  7. SELLMGNIMAGNITE, INC.Nov 5 – Nov 127 insiders$2.27M
  8. SELLSYMSymbotic Inc.Oct 26 – Nov 27 insiders$1.98M

Form 4 transactions

72,558 records
Side
allbuysell
Score
any≥ 30≥ 50≥ 70
Sort
Newest disclosedNewest executedInsider ScoreValue
Include
grants & admin
ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
17
RR
Ribeiro RamiroChief Medical Officer
EYPTEyePoint, Inc.
Option exercise
M—
19.7K sh
Jan 3, 2026Jan 6, 2026
Page 1532 of 1814
← PrevNext →
traded Jan 3, 2026
+3d
SEC Form 4

Evidence

17
GK
Guarini KathrynDirector
REGNREGENERON PHARMACEUTICALS, INC.
Grant or award
A—
155 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

17
SC
Swanton Robert CharlesDirector
BCYCBICYCLE THERAPEUTICS PLC
Grant or award
A—
3,726 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

17
JM
Johnson Gwendolyn MarySVP - Asset Management
EPREPR PROPERTIES
Grant or award
A—
4,562 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

16
HJ
Hay Laura JDirector
METMETLIFE INC
Grant or award
A$51K
639 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

16
LT
Lovalekar TusharVP, Information Technology
KOPKoppers Holdings Inc.
Tax withholding
F$55K
2,032 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

16
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$34K
400 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

16
JM
Johnson Gwendolyn MarySVP - Asset Management
EPREPR PROPERTIES
Tax withholding
F$182K
3,652 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

16
CJ
Carlson Anthony JDirector, President and CEO
ADARRAY DIGITAL INFRASTRUCTURE, INC.
Tax withholding
F$73K
1,355 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

16
MD
Middleton Piers DayerEVP & Chief Operating Officer
TDWTIDEWATER INC
Tax withholding
F$107K
2,053 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

16
KR
Kelleher Eric RobertSee Remarks
OKTAOkta, Inc.
Open-market sale · 10b5-1 plan
SELL$26K
300 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

16
MA
Moriarty Brian AndrewSVP - Corporate Communications
EPREPR PROPERTIES
Tax withholding
F$71K
1,430 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

15
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$23K
361 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

15
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$9,132
145 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

15
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$18K
285 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

15
SS
Sahni Sanjeev SinghPresident
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$25K
392 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

15
BM
Bazar Gregory MatthewDirector
SNVWSANUWAVE Health, Inc.
Grant or award
A—
1,540 sh
Dec 31, 2025Jan 6, 2026
traded Dec 31, 2025
+6dSEC Form 4

Evidence

15
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$22K
339 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

15
BC
Blevins ChristopherGeneral Counsel
SBDSSolo Brands, Inc.
Tax withholding
F$30.25
5 sh
Jan 1, 2026Jan 6, 2026
traded Jan 1, 2026
+5dSEC Form 4

Evidence

15
MD
Miller Ian D.Director
SNVWSANUWAVE Health, Inc.
Grant or award
A—
1,733 sh
Dec 31, 2025Jan 6, 2026
traded Dec 31, 2025
+6dSEC Form 4

Evidence

15
RV
Raghavan VaidyanathanChief Technology Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$29K
434 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

15
BJ
Blizard JeffreyDirector
SNVWSANUWAVE Health, Inc.
Grant or award
A—
1,540 sh
Dec 31, 2025Jan 6, 2026
traded Dec 31, 2025
+6dSEC Form 4

Evidence

15
TJ
Tyler JamesDirector
SNVWSANUWAVE Health, Inc.
Grant or award
A—
1,540 sh
Dec 31, 2025Jan 6, 2026
traded Dec 31, 2025
+6dSEC Form 4

Evidence

14
MP
Mazzara PhilipGeneral Counsel and Secretary
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$104K
600 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

14
MP
Mazzara PhilipGeneral Counsel and Secretary
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$192K
1,100 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

14
EO
Espinoza OctavioChief Financial Officer
LGNDLIGAND PHARMACEUTICALS INC
Other acquisition or disposition
J$765
8 sh
Dec 31, 2025Jan 6, 2026
traded Dec 31, 2025
+6dSEC Form 4

Evidence

14
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$163K
2,500 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

14
DS
Dutt SubirChief Sales Officer
XMTRXometry, Inc.
Open-market sale · 10b5-1 plan
SELL$60K
899 sh
Jan 5, 2026Jan 6, 2026
traded Jan 5, 2026
+1dSEC Form 4

Evidence

14
MP
Mazzara PhilipGeneral Counsel and Secretary
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$88K
500 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

14
MP
Mazzara PhilipGeneral Counsel and Secretary
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$237K
1,319 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

14
MP
Mazzara PhilipGeneral Counsel and Secretary
ALABAstera Labs, Inc.
Open-market sale · 10b5-1 plan
SELL$235K
1,300 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

13
FT
Foote TimChief Financial Officer
BBBLACKBERRY Ltd
Option exercise
M—
7,375 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

13
LT
Lovalekar TusharVP, Information Technology
KOPKoppers Holdings Inc.
Grant or award
A—
10 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

13
RP
Rayphole Robert P.VP CAO & Controller
APAAPA Corp
Disposition to issuer
D$22K
880 sh
Jan 4, 2026Jan 6, 2026
traded Jan 4, 2026
+2dSEC Form 4

Evidence

13
RP
Rayphole Robert P.VP CAO & Controller
APAAPA Corp
Option exercise
M—
880 sh
Jan 4, 2026Jan 6, 2026
traded Jan 4, 2026
+2dSEC Form 4

Evidence

13
TR
Turvey Paul RobertSVP & Assoc. General Counsel
EPREPR PROPERTIES
Grant or award
A—
4,008 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

13
BG
Bove David GChief Information Officer/SVP
UNTYUNITY BANCORP INC /NJ/
Tax withholding
F$8,581
168 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

13
MJ
Mokry Anthony JohnSVP Residential Services
CABOCable One, Inc.
Tax withholding
F$26K
250 sh
Jan 3, 2026Jan 6, 2026
traded Jan 3, 2026
+3dSEC Form 4

Evidence

13
AV
Altamura Michelle VervaisEVP, General Counsel, Sec.
IRMIRON MOUNTAIN INC
Tax withholding
F$39K
469 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence

13
RP
Rayphole Robert P.VP CAO & Controller
APAAPA Corp
Option exercise
M—
948 sh
Jan 2, 2026Jan 6, 2026
traded Jan 2, 2026
+4dSEC Form 4

Evidence